Company Name: NovoCure Limited
NovoCure Limited is a commercial-stage oncology company. The company’s proprietary Tumor Treating Fields therapy is designed to treat solid tumor cancers. The company’s first FDA approved Tumor Treating Fields delivery system is a monotherapy treatment designed to treat glioblastoma brain cancer.
Ticker Symbol: NVCR (NASDAQ)
Company Website: www.novocure.com
Headquarters: St. Helier, Jersey Isle, Channel Islands